• The University of Western Australia (M560), 35 Stirling Highway,

    6009 Perth

    Australia

  • 924 Citations
  • 17 h-Index
20112021
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Glioblastoma Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Glioma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Ectopic Pregnancy Medicine & Life Sciences
Cells Chemical Compounds
Mitochondrial DNA Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2018

  • 924 Citations
  • 17 h-Index
  • 37 Article
  • 1 Editorial
  • 1 Review article
1 Citations

Activation of ERBB4 in glioblastoma can contribute to increased tumorigenicity and influence therapeutic response

Donoghue, J. F., Kerr, L. T., Alexander, N. W., Greenall, S. A., Longano, A. B., Gottardo, N. G., Wang, R., Tabar, V., Adams, T. E., Mischel, P. S. & Johns, T. G., 1 Aug 2018, In : Cancers. 10, 8, 243

Research output: Contribution to journalArticle

Open Access
Glioblastoma
Therapeutics
Heterografts
Messenger RNA
Survival
1 Citations

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors

Endersby, R., Whitehouse, J., Hii, H., Greenall, S. A., Johns, T. G. & Gottardo, N. G., May 2018, In : Neoplasia. 20, 5, p. 432-442 11 p.

Research output: Contribution to journalArticle

Open Access
Medulloblastoma
Brain Neoplasms
Glioblastoma
Epidermal Growth Factor Receptor
Pediatrics

Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors

Hoque, M., Abbassi, R. H., Froio, D., Man, J., Johns, T. G., Stringer, B. W., Day, B. W., Pajic, M., Kassiou, M. & Munoz, L., 1 Aug 2018, In : Pharmacological Research. 134, p. 166-178 13 p.

Research output: Contribution to journalArticle

Tubulin
Protein Kinase Inhibitors
Phosphotransferases
Drug Delivery Systems
Pharmacology

Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3

Greenall, S. A., Donoghue, J., Johns, T. G. & Adams, T. E., 1 Aug 2018, In : Translational Oncology. 11, 4, p. 971-978 8 p.

Research output: Contribution to journalArticle

Open Access
Insulin-Like Growth Factor II
Neutralizing Antibodies
Heterografts
Hepatocellular Carcinoma
Cell Line
8 Citations

Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma

Greenall, S. A., Lim, Y. C., Mitchell, C. B., Ensbey, K. S., Stringer, B. W., Wilding, A. L., O'Neill, G. M., McDonald, K. L., Gough, D. J., Day, B. W. & Johns, T. G., 15 May 2017, In : Oncogenesis. 6, e336

Research output: Contribution to journalArticle

Open Access
Cyclin-Dependent Kinases
Glioma
Transcriptome
Cell Cycle
G2 Phase Cell Cycle Checkpoints